UNIGE document Scientific Article
previous document  unige:81165  next document
add to browser collection

Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters

Lopez, Renata Fonseca Vianna
Lopes Badra Bentley, Maria Vitória
Published in Advanced Drug Delivery Reviews. 2004, vol. 56, no. 1, p. 77-94
Abstract Photodynamic therapy (PDT) is a tool for the treatment of certain cancerous and pre-cancerous conditions in dermatology. 5-Aminolevulinic acid (5-ALA) and simple derivatives thereof are the principal compounds used for this purpose. For optimal efficacy, the drug must be released at an appropriate rate from the formulation and penetrate the skin, ideally to reach the target tissue at a sufficiently high concentration. Because ALA is a polar, zwitterionic compound, its formulation in conventional topical vehicles, and its inherently poor skin permeability, poses important challenges for the pharmaceutical scientist. The synthesis of more lipophilic (e.g. ester) prodrugs of ALA resolves, in part, these issues but then demands that questions, related to biotransformation back to the parent 5-ALA and to stability, be addressed. The objective of this review, therefore, is to evaluate the state-of-the-art and identify those areas in which additional research is necessary.
Keywords Photodynamic therapy5-ALA5-ALA derivativesSkin penetrationSkin cancerProtoporphyrin IX
PMID: 14706446
Full text
Article (Published version) (612 Kb) - document accessible for UNIGE members only Limited access to UNIGE
(ISO format)
LOPEZ, Renata Fonseca Vianna et al. Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters. In: Advanced Drug Delivery Reviews, 2004, vol. 56, n° 1, p. 77-94. https://archive-ouverte.unige.ch/unige:81165

153 hits

0 download


Deposited on : 2016-03-01

Export document
Format :
Citation style :